Comera Life Sciences Holdings, Inc.
DelistedCIK 1907685fmd_0AJNRZY3FP5RMT95JKRKEWYGHBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 12 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 0 | 0 | 1 |
| Cost of revenue | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 |
| Research and development | 1 | 2 | 2 |
| Total operating expenses | 2 | 6 | 12 |
| Operating income | (2) | (6) | (12) |
| Interest expense | – | – | 0 |
| Other non-operating income (expense) | 0 | 0 | (6) |
| Income tax expense | – | – | 0 |
| Net income | (2) | (5) | (18) |